UK's MHRA Releases Annual Report Detailing Strong Performance and Global Impact

The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has published its annual report for 2025-26, showcasing a year of significant achievements. The report highlights the approval of numerous medicinal products, efficient processing of clinical trial applications, and the successful removal of millions of illegally traded medicines. Additionally, the MHRA's growing influence in global healthcare, including its role in AI regulation and accelerating patient access to new treatments, was emphasized.